An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania

Liyen Loh,Philippa M Saunders,Camilla Faoro,Neus Font-Porterias,Neda Nemat-Gorgani,Genelle F Harrison,Suraju Sadeeq,Luca Hensen,Shu Cheng Wong,Jacqueline Widjaja,E Bridie Clemens,Shiying Zhu,Katherine M Kichula,Sudan Tao,Faming Zhu,Gonzalo Montero-Martin,Marcelo Fernandez-Vina,Lisbeth A Guethlein,Julian P Vivian,Jane Davies,Alexander J Mentzer,Stephen J Oppenheimer,William Pomat,Alexander G Ioannidis,Carmina Barberena-Jonas,Oceanian Genome Variation Project Consortium,Andrés Moreno-Estrada,Adrian Miller,Peter Parham,Jamie Rossjohn,Steven Y C Tong,Katherine Kedzierska,Andrew G Brooks,Paul J Norman

DOI: https://doi.org/10.1016/j.cell.2024.10.005

IF: 64.5

2024-10-29

Cell

Abstract:Genetic variation in host immunity impacts the disproportionate burden of infectious diseases that can be experienced by First Nations peoples. Polymorphic human leukocyte antigen (HLA) class I and killer cell immunoglobulin-like receptors (KIRs) are key regulators of natural killer (NK) cells, which mediate early infection control. How this variation impacts their responses across populations is unclear. We show that HLA-A∗24:02 became the dominant ligand for inhibitory KIR3DL1 in First Nations peoples across Oceania, through positive natural selection. We identify KIR3DL1∗114, widespread across and unique to Oceania, as an allele lineage derived from archaic humans. KIR3DL1∗114+NK cells from First Nations Australian donors are inhibited through binding HLA-A∗24:02. The KIR3DL1∗114 lineage is defined by phenylalanine at residue 166. Structural and binding studies show phenylalanine 166 forms multiple unique contacts with HLA-peptide complexes, increasing both affinity and specificity. Accordingly, assessing immunogenetic variation and the functional implications for immunity are fundamental toward understanding population-based disease associations.